Loading…
Severe acute respiratory syndrome coronavirus 2 infection rate among pediatric patients with respiratory symptoms
The incidence of coronavirus disease 2019 (COVID-19) in children has been increasing worldwide since the onset of the pandemic. This study examined the risk factors and characteristics of COVID-19 among pediatric patients compared to other respiratory viral infections. This was a prospective cross-s...
Saved in:
Published in: | Pediatrics international 2024-01, Vol.66 (1), p.e15740-e15740 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c245t-9c0811ec52695f2af0fa84c15437307d80dee11bdc0b84f3ec18528cdc74fa823 |
container_end_page | e15740 |
container_issue | 1 |
container_start_page | e15740 |
container_title | Pediatrics international |
container_volume | 66 |
creator | Samerton, Penpitcha Apiwattanakul, Nopporn Assawawiroonhakarn, Surapat Sahakijpicharn, Thiantip Thongchai, Rakruthai Techasaensiri, Chonnamet Boonsathorn, Sophida Chaisavaneeyakorn, Sujittra |
description | The incidence of coronavirus disease 2019 (COVID-19) in children has been increasing worldwide since the onset of the pandemic. This study examined the risk factors and characteristics of COVID-19 among pediatric patients compared to other respiratory viral infections.
This was a prospective cross-sectional study. Patients aged 0-18 years presenting with respiratory symptoms from October 2020 to December 2021 were included. Demographic and clinical data were reviewed.
In total, 738 pediatric patients were enrolled. Of these, 48.5% had COVID-19, and 41.3% were infected with another respiratory virus. The COVID-19 incidence increased from 0.5% during the original strain outbreak (October 2020 to March 2021) to 56.5% and 73.4% during the alpha (April to June 2021) and delta (July to December 2021) periods, respectively. Children aged 6-18 years, being female, obesity, exposure to household members with COVID-19, and the delta period were risk factors for COVID-19. Being aged 1-5 years, obesity, shortness of breath, productive cough, and chest pain were associated with COVID-19 pneumonia. Children aged 5-18 years, underlying neurological disease, a history of COVID-19 pneumonia, and the delta period were associated with long COVID.
Pediatric COVID-19 patients presenting with respiratory symptoms who are obese or have been exposed to household members with COVID-19 should be tested for COVID-19. COVID-19 patients who are obese, younger than five years old, or who present with shortness of breath, productive cough, or chest pain should be evaluated for pneumonia. COVID-19 patients with a history of COVID-19 pneumonia or underlying neurological disease should receive follow-up for long COVID. |
doi_str_mv | 10.1111/ped.15740 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3043076463</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3043076463</sourcerecordid><originalsourceid>FETCH-LOGICAL-c245t-9c0811ec52695f2af0fa84c15437307d80dee11bdc0b84f3ec18528cdc74fa823</originalsourceid><addsrcrecordid>eNpdkD1PwzAQhi0EoqUw8AeQRxhSzh9J3BFVfEmVGACJLXKdCxg1cWo7Rf33GGgXvJx1eu7R3UvIOYMpS--6x3rK8lLCARkzKXnGAd4O019wlSkoyhE5CeETAFSp5DEZCVVINhP5mKyfcYMeqTZDROox9Nbr6PyWhm1Xe9ciNc67Tm-sHwLl1HYNmmhdRxOX5lrXvdO0gNXRW0N7HS12MdAvGz_--do-ujackqNGrwKe7eqEvN7dvswfssXT_eP8ZpEZLvOYzQwoxtDkvJjlDdcNNFpJw3IpSgFlraBGZGxZG1gq2Qg0TOVcmdqUMpFcTMjln7f3bj1giFVrg8HVSnfohlAJkMlTyEIk9OoPNd6F4LGpem9b7bcVg-on4SodWP0mnNiLnXZYtqm7J_eRim819nmx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3043076463</pqid></control><display><type>article</type><title>Severe acute respiratory syndrome coronavirus 2 infection rate among pediatric patients with respiratory symptoms</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Samerton, Penpitcha ; Apiwattanakul, Nopporn ; Assawawiroonhakarn, Surapat ; Sahakijpicharn, Thiantip ; Thongchai, Rakruthai ; Techasaensiri, Chonnamet ; Boonsathorn, Sophida ; Chaisavaneeyakorn, Sujittra</creator><creatorcontrib>Samerton, Penpitcha ; Apiwattanakul, Nopporn ; Assawawiroonhakarn, Surapat ; Sahakijpicharn, Thiantip ; Thongchai, Rakruthai ; Techasaensiri, Chonnamet ; Boonsathorn, Sophida ; Chaisavaneeyakorn, Sujittra</creatorcontrib><description>The incidence of coronavirus disease 2019 (COVID-19) in children has been increasing worldwide since the onset of the pandemic. This study examined the risk factors and characteristics of COVID-19 among pediatric patients compared to other respiratory viral infections.
This was a prospective cross-sectional study. Patients aged 0-18 years presenting with respiratory symptoms from October 2020 to December 2021 were included. Demographic and clinical data were reviewed.
In total, 738 pediatric patients were enrolled. Of these, 48.5% had COVID-19, and 41.3% were infected with another respiratory virus. The COVID-19 incidence increased from 0.5% during the original strain outbreak (October 2020 to March 2021) to 56.5% and 73.4% during the alpha (April to June 2021) and delta (July to December 2021) periods, respectively. Children aged 6-18 years, being female, obesity, exposure to household members with COVID-19, and the delta period were risk factors for COVID-19. Being aged 1-5 years, obesity, shortness of breath, productive cough, and chest pain were associated with COVID-19 pneumonia. Children aged 5-18 years, underlying neurological disease, a history of COVID-19 pneumonia, and the delta period were associated with long COVID.
Pediatric COVID-19 patients presenting with respiratory symptoms who are obese or have been exposed to household members with COVID-19 should be tested for COVID-19. COVID-19 patients who are obese, younger than five years old, or who present with shortness of breath, productive cough, or chest pain should be evaluated for pneumonia. COVID-19 patients with a history of COVID-19 pneumonia or underlying neurological disease should receive follow-up for long COVID.</description><identifier>ISSN: 1328-8067</identifier><identifier>EISSN: 1442-200X</identifier><identifier>DOI: 10.1111/ped.15740</identifier><identifier>PMID: 38641935</identifier><language>eng</language><publisher>Australia</publisher><subject>Chest Pain ; Child ; Child, Preschool ; Cough - epidemiology ; Cough - etiology ; COVID-19 - epidemiology ; Cross-Sectional Studies ; Dyspnea ; Female ; Humans ; Male ; Obesity ; Post-Acute COVID-19 Syndrome ; Prospective Studies ; SARS-CoV-2</subject><ispartof>Pediatrics international, 2024-01, Vol.66 (1), p.e15740-e15740</ispartof><rights>2024 Japan Pediatric Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c245t-9c0811ec52695f2af0fa84c15437307d80dee11bdc0b84f3ec18528cdc74fa823</cites><orcidid>0000-0002-6027-0534 ; 0000-0003-1833-5127 ; 0000-0001-8166-8691</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38641935$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Samerton, Penpitcha</creatorcontrib><creatorcontrib>Apiwattanakul, Nopporn</creatorcontrib><creatorcontrib>Assawawiroonhakarn, Surapat</creatorcontrib><creatorcontrib>Sahakijpicharn, Thiantip</creatorcontrib><creatorcontrib>Thongchai, Rakruthai</creatorcontrib><creatorcontrib>Techasaensiri, Chonnamet</creatorcontrib><creatorcontrib>Boonsathorn, Sophida</creatorcontrib><creatorcontrib>Chaisavaneeyakorn, Sujittra</creatorcontrib><title>Severe acute respiratory syndrome coronavirus 2 infection rate among pediatric patients with respiratory symptoms</title><title>Pediatrics international</title><addtitle>Pediatr Int</addtitle><description>The incidence of coronavirus disease 2019 (COVID-19) in children has been increasing worldwide since the onset of the pandemic. This study examined the risk factors and characteristics of COVID-19 among pediatric patients compared to other respiratory viral infections.
This was a prospective cross-sectional study. Patients aged 0-18 years presenting with respiratory symptoms from October 2020 to December 2021 were included. Demographic and clinical data were reviewed.
In total, 738 pediatric patients were enrolled. Of these, 48.5% had COVID-19, and 41.3% were infected with another respiratory virus. The COVID-19 incidence increased from 0.5% during the original strain outbreak (October 2020 to March 2021) to 56.5% and 73.4% during the alpha (April to June 2021) and delta (July to December 2021) periods, respectively. Children aged 6-18 years, being female, obesity, exposure to household members with COVID-19, and the delta period were risk factors for COVID-19. Being aged 1-5 years, obesity, shortness of breath, productive cough, and chest pain were associated with COVID-19 pneumonia. Children aged 5-18 years, underlying neurological disease, a history of COVID-19 pneumonia, and the delta period were associated with long COVID.
Pediatric COVID-19 patients presenting with respiratory symptoms who are obese or have been exposed to household members with COVID-19 should be tested for COVID-19. COVID-19 patients who are obese, younger than five years old, or who present with shortness of breath, productive cough, or chest pain should be evaluated for pneumonia. COVID-19 patients with a history of COVID-19 pneumonia or underlying neurological disease should receive follow-up for long COVID.</description><subject>Chest Pain</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cough - epidemiology</subject><subject>Cough - etiology</subject><subject>COVID-19 - epidemiology</subject><subject>Cross-Sectional Studies</subject><subject>Dyspnea</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Obesity</subject><subject>Post-Acute COVID-19 Syndrome</subject><subject>Prospective Studies</subject><subject>SARS-CoV-2</subject><issn>1328-8067</issn><issn>1442-200X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpdkD1PwzAQhi0EoqUw8AeQRxhSzh9J3BFVfEmVGACJLXKdCxg1cWo7Rf33GGgXvJx1eu7R3UvIOYMpS--6x3rK8lLCARkzKXnGAd4O019wlSkoyhE5CeETAFSp5DEZCVVINhP5mKyfcYMeqTZDROox9Nbr6PyWhm1Xe9ciNc67Tm-sHwLl1HYNmmhdRxOX5lrXvdO0gNXRW0N7HS12MdAvGz_--do-ujackqNGrwKe7eqEvN7dvswfssXT_eP8ZpEZLvOYzQwoxtDkvJjlDdcNNFpJw3IpSgFlraBGZGxZG1gq2Qg0TOVcmdqUMpFcTMjln7f3bj1giFVrg8HVSnfohlAJkMlTyEIk9OoPNd6F4LGpem9b7bcVg-on4SodWP0mnNiLnXZYtqm7J_eRim819nmx</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Samerton, Penpitcha</creator><creator>Apiwattanakul, Nopporn</creator><creator>Assawawiroonhakarn, Surapat</creator><creator>Sahakijpicharn, Thiantip</creator><creator>Thongchai, Rakruthai</creator><creator>Techasaensiri, Chonnamet</creator><creator>Boonsathorn, Sophida</creator><creator>Chaisavaneeyakorn, Sujittra</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6027-0534</orcidid><orcidid>https://orcid.org/0000-0003-1833-5127</orcidid><orcidid>https://orcid.org/0000-0001-8166-8691</orcidid></search><sort><creationdate>202401</creationdate><title>Severe acute respiratory syndrome coronavirus 2 infection rate among pediatric patients with respiratory symptoms</title><author>Samerton, Penpitcha ; Apiwattanakul, Nopporn ; Assawawiroonhakarn, Surapat ; Sahakijpicharn, Thiantip ; Thongchai, Rakruthai ; Techasaensiri, Chonnamet ; Boonsathorn, Sophida ; Chaisavaneeyakorn, Sujittra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c245t-9c0811ec52695f2af0fa84c15437307d80dee11bdc0b84f3ec18528cdc74fa823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Chest Pain</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cough - epidemiology</topic><topic>Cough - etiology</topic><topic>COVID-19 - epidemiology</topic><topic>Cross-Sectional Studies</topic><topic>Dyspnea</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Obesity</topic><topic>Post-Acute COVID-19 Syndrome</topic><topic>Prospective Studies</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Samerton, Penpitcha</creatorcontrib><creatorcontrib>Apiwattanakul, Nopporn</creatorcontrib><creatorcontrib>Assawawiroonhakarn, Surapat</creatorcontrib><creatorcontrib>Sahakijpicharn, Thiantip</creatorcontrib><creatorcontrib>Thongchai, Rakruthai</creatorcontrib><creatorcontrib>Techasaensiri, Chonnamet</creatorcontrib><creatorcontrib>Boonsathorn, Sophida</creatorcontrib><creatorcontrib>Chaisavaneeyakorn, Sujittra</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Samerton, Penpitcha</au><au>Apiwattanakul, Nopporn</au><au>Assawawiroonhakarn, Surapat</au><au>Sahakijpicharn, Thiantip</au><au>Thongchai, Rakruthai</au><au>Techasaensiri, Chonnamet</au><au>Boonsathorn, Sophida</au><au>Chaisavaneeyakorn, Sujittra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe acute respiratory syndrome coronavirus 2 infection rate among pediatric patients with respiratory symptoms</atitle><jtitle>Pediatrics international</jtitle><addtitle>Pediatr Int</addtitle><date>2024-01</date><risdate>2024</risdate><volume>66</volume><issue>1</issue><spage>e15740</spage><epage>e15740</epage><pages>e15740-e15740</pages><issn>1328-8067</issn><eissn>1442-200X</eissn><abstract>The incidence of coronavirus disease 2019 (COVID-19) in children has been increasing worldwide since the onset of the pandemic. This study examined the risk factors and characteristics of COVID-19 among pediatric patients compared to other respiratory viral infections.
This was a prospective cross-sectional study. Patients aged 0-18 years presenting with respiratory symptoms from October 2020 to December 2021 were included. Demographic and clinical data were reviewed.
In total, 738 pediatric patients were enrolled. Of these, 48.5% had COVID-19, and 41.3% were infected with another respiratory virus. The COVID-19 incidence increased from 0.5% during the original strain outbreak (October 2020 to March 2021) to 56.5% and 73.4% during the alpha (April to June 2021) and delta (July to December 2021) periods, respectively. Children aged 6-18 years, being female, obesity, exposure to household members with COVID-19, and the delta period were risk factors for COVID-19. Being aged 1-5 years, obesity, shortness of breath, productive cough, and chest pain were associated with COVID-19 pneumonia. Children aged 5-18 years, underlying neurological disease, a history of COVID-19 pneumonia, and the delta period were associated with long COVID.
Pediatric COVID-19 patients presenting with respiratory symptoms who are obese or have been exposed to household members with COVID-19 should be tested for COVID-19. COVID-19 patients who are obese, younger than five years old, or who present with shortness of breath, productive cough, or chest pain should be evaluated for pneumonia. COVID-19 patients with a history of COVID-19 pneumonia or underlying neurological disease should receive follow-up for long COVID.</abstract><cop>Australia</cop><pmid>38641935</pmid><doi>10.1111/ped.15740</doi><orcidid>https://orcid.org/0000-0002-6027-0534</orcidid><orcidid>https://orcid.org/0000-0003-1833-5127</orcidid><orcidid>https://orcid.org/0000-0001-8166-8691</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1328-8067 |
ispartof | Pediatrics international, 2024-01, Vol.66 (1), p.e15740-e15740 |
issn | 1328-8067 1442-200X |
language | eng |
recordid | cdi_proquest_miscellaneous_3043076463 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Chest Pain Child Child, Preschool Cough - epidemiology Cough - etiology COVID-19 - epidemiology Cross-Sectional Studies Dyspnea Female Humans Male Obesity Post-Acute COVID-19 Syndrome Prospective Studies SARS-CoV-2 |
title | Severe acute respiratory syndrome coronavirus 2 infection rate among pediatric patients with respiratory symptoms |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T01%3A39%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection%20rate%20among%20pediatric%20patients%20with%20respiratory%20symptoms&rft.jtitle=Pediatrics%20international&rft.au=Samerton,%20Penpitcha&rft.date=2024-01&rft.volume=66&rft.issue=1&rft.spage=e15740&rft.epage=e15740&rft.pages=e15740-e15740&rft.issn=1328-8067&rft.eissn=1442-200X&rft_id=info:doi/10.1111/ped.15740&rft_dat=%3Cproquest_cross%3E3043076463%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c245t-9c0811ec52695f2af0fa84c15437307d80dee11bdc0b84f3ec18528cdc74fa823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3043076463&rft_id=info:pmid/38641935&rfr_iscdi=true |